MOTS-c (Mitochondrial Peptide)

Two Methionines in Sixteen Residues

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

MOTS-c is MRWQEMGYIFYPRKLR: methionine at positions 1 and 6, two residues in sixteen. At 12.5% methionine against roughly 2.3% across proteins generally, it is around five times enriched, consistent with its mitochondrial origin.

Key facts

Sequence
H-MRWQEMGYIFYPRKLR-OH
Length
16 residues
Methionines
Two (positions 1 and 6)
Methionine fraction
12.5%
Typical across proteins
About 2.3%
Formula
C101H152N28O22S2
Cysteines
None

The arithmetic

Two methionines in a sixteen-residue peptide is one residue in eight. Methionine is among the less common amino acids, appearing at roughly 2.3% across proteins generally. Twelve and a half per cent is therefore around a five-fold enrichment, which is large enough to be worth explaining rather than dismissing as chance in a short sequence.

The formula corroborates it

C101H152N28O22S2. Two sulfur atoms, and no cysteine in the sequence, so both sulfurs are methionine thioethers. The molecular formula and the stated sequence agree with each other, which is a basic internal consistency check worth performing on any certificate and one that several compounds audited on this site failed.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

Why the enrichment is not surprising

MOTS-c is encoded within mitochondrial DNA, and the vertebrate mitochondrial genetic code reassigns AUA from isoleucine to methionine. Bender and colleagues argued in PNAS in 2008 that this reassignment exists because it raises methionine content for antioxidant purposes. A methionine-rich peptide from that genome is the predicted result, not a coincidence.

What it means for handling

Two oxidation-prone residues rather than one. Each oxidises to the sulfoxide at +16 Da, so a degraded preparation can show +16 and +32 satellites alongside the parent mass at 2,174.6 Da. Two sites means the probability that at least one has oxidised rises faster with time and exposure than for a single-methionine peptide.

What it means analytically

The satellites are diagnostic. A +16 Da species is not an unidentified impurity. It is the parent compound with one methionine oxidised, and its presence quantifies how much oxidation has occurred. That makes MOTS-c unusually easy to assess for this particular form of degradation, which is a small compensation for being unusually prone to it.

And what it does not mean

That oxidised material is equivalent to intact material, or that a preparation showing satellites is acceptable. Oxidation changes the molecule, and a certificate should be read for whether the parent mass dominates. Material supplied here is for laboratory research only and no claim is made about any effect in any person.

Quick reference

MOTS-cTypical protein
Methionine fraction12.5% (2 of 16)~2.3%
CysteineNone~1.4%
Sulfur atoms2, both methionineMixed Met and Cys

Frequently asked questions

How much methionine does MOTS-c contain?

Two residues of sixteen: 12.5%, against roughly 2.3% across proteins generally, so about five-fold enriched.

Why is it so methionine-rich?

It is encoded in mitochondrial DNA, whose genetic code reassigns AUA from isoleucine to methionine, a change argued to exist for antioxidant reasons.

What does that mean in practice?

Two oxidation-prone sites rather than one, producing diagnostic +16 and +32 Da satellites alongside the 2,174.6 Da parent mass.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.